Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Andrea Pais
CEO
andrea@novelmicrodevices.com

Message the company or request a 1:1 meeting here

Novel Microdevices is a woman-owned, woman-led point-of-care infectious disease diagnostics company headquartered in Baltimore City, Maryland. Novel Microdevices is commercializing Novel Dx, a proprietary and best-in-class Point-of-Care (POC) rapid molecular diagnostics system that is ultra-portable, cloud-connected and can be produced for a wide range of high-volume molecular diagnostic assay applications. The company is focusing on women’s health and under-resourced populations in the $31 billion infectious diseases diagnostics market with tests in development for multiple respiratory and sexually transmitted infections. Most recently, the company was awarded $13.8M in funding from CARB-X.